Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hinton

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Noise & Health|April 8, 2003
How to Map NoiseJohn Hinton
Documentation in Medical Ethics|January 1, 1975
Patients' attitudes to dyingJohn Hinton
Environmental Science & Technology|July 9, 2016
Geophysical Monitoring of Hydrocarbon-Contaminated Soils Remediated with a Bioelectrochemical SystemDeqiang Mao, Lu Lu, André Revil, et al.
The Lancet. Neurology|April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 studyJames F Howard, Saskia Bresch, Angela Genge, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Noise & Health|April 8, 2003
How to Map NoiseJohn Hinton
Documentation in Medical Ethics|January 1, 1975
Patients' attitudes to dyingJohn Hinton
Environmental Science & Technology|July 9, 2016
Geophysical Monitoring of Hydrocarbon-Contaminated Soils Remediated with a Bioelectrochemical SystemDeqiang Mao, Lu Lu, André Revil, et al.
The Lancet. Neurology|April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 studyJames F Howard, Saskia Bresch, Angela Genge, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Pageof 1